ALINITY I SYPHILIS TP REAGENT KIT 07P60-77

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2020-01-15 for ALINITY I SYPHILIS TP REAGENT KIT 07P60-77 manufactured by Abbott Gmbh.

Event Text Entries

[188028489] Patient information: no further patient information was provided by the customer. An evaluation is in process. A follow-up report will be submitted when the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[188028490] The customer observed a (b)(6) alinity i syphilis tp result for (b)(6) female patient. The following data was provided: on (b)(4) 2020 (b)(4) initial result = 0. 54 (b)(6)), colloidal gold = (b)(6), elisa = (b)(6), patient was positive a year ago with chemiluminescence and elisa testing. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[188028687] A review of tickets was performed for reagent lot number 03516be01. The ticket search determined that there is normal complaint activity for the likely cause lot. A review of tracking and trending did not identify any trends for the complaint issue. Return testing was not completed as returns were not available. Retained reagent kits of lot number 03516be00 (which contains the same bulk material as 03516be01) were tested in a sensitivity setup, including additional replicates of positive control. Results of this setup were in typical range and no false non-reactive results were obtained. Additionally, the architect syphilis tp reagent, lot number 03540be00 (which contains identical bulk reagents) was also tested as this test setup includes testing of a sensitivity panel. This included additional replicates of the testing panel. Results of this setup were in typical range and no false non-reactive results were obtained. All generated data demonstrate that the performance of the alinity i syphilis tp reagent, lot number 03516be00 is not compromised. A review of the manufacturing documentation did not identify any issues associated with the complaint issue. A review of labeling concluded that the issue is sufficiently addressed. Based on the investigation no systemic issue or deficiency of the alinity i syphilis tp assay for lot 03516be01 was identified. This report is being filed on an international product, list number 7p60-32 that has a similar product distributed in the us, list number 7p60-21/31.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002809144-2020-00043
MDR Report Key9590439
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2020-01-15
Date of Report2020-04-03
Date of Event2020-01-08
Date Mfgr Received2020-03-25
Device Manufacturer Date2019-08-06
Date Added to Maude2020-01-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCHRISTIAN LEE
Manufacturer Street100 ABBOTT PARK ROAD DEPT 09B9, BLDG CP01-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224668-294
Manufacturer G1ABBOTT GMBH
Manufacturer StreetMAX-PLANCK-RING 2
Manufacturer CityWIESBADEN 65205
Manufacturer CountryGM
Manufacturer Postal Code65205
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameALINITY I SYPHILIS TP REAGENT KIT
Generic NameALINITY I SYPHILIS TP
Product CodeMTN
Date Received2020-01-15
Catalog Number07P60-77
Lot Number03516BE01
Device Expiration Date2020-03-25
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT GMBH
Manufacturer AddressMAX-PLANCK-RING 2 WIESBADEN 65205 GM 65205


Patients

Patient NumberTreatmentOutcomeDate
10 2020-01-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.